Three for MatrixOne

Collaboration provider scores trio of new customers

Tempe, AZ ­ -- February 18, 2002 -- ­Software provider MatrixOne scored a three-peat in recent weeks, announcing a trio of new customers for the company's product collaboration solutions.

First, Venture Industries, North America's largest private tier-one automotive supplier, will use the solution provider's flagship eMatrix collaboration platform to better manage projects by providing a unified view of project status in real-time. Venture is hoping to cut costs by streamlining its product development lifecycle and enabling real-time access to data that resides on multiple systems across the world.

Venture, headquartered in Fraser, Mich., is a $2.3 billion automotive supplier, providing advanced engineering, materials, manufacturing and logistics technologies through its facilities and alliances on five continents.

"Our industry requires us to conform to varied automobile design data, and we need to have the right specifications and materials for our OEMs [original equipment manufacturers] while at times using other suppliers¹ data, a process that can be very complicated," said Charles Hunter, a president at Venture. "MatrixOne's solutions will allow our senior management team to easily view this critical information, allowing them to make important business decisions based on the most up-to-date data."

Meanwhile, Siemens Dematic, the world's largest supplier of production and logistics automation systems, is set to implement MatrixOne's solutions in an effort to help standardize its engineering collaboration efforts.

Nuremberg, Germany-based Siemens Dematic, formed from the July 2001 merger of the Siemens Production and Logistics Systems group with Mannesmann Dematic AG, is a $3.2 billion company employing nearly 11,500 people worldwide. Following the merger, the company needed to facilitate the sharing of designs and information among all of its global units, as well as greater collaboration with suppliers and customers.

"Merging the operations of two large entities made it imperative for us to make our engineering processes more efficient," said Pete Metros, president of Siemens Dematic's material handling automation division.

MatrixOne will provide a single, global repository of content and knowledge that will provide Siemens Dematic's employees, suppliers and customers with dynamic access to the up-to-date product and project information.

Using eMatrix, Siemens Dematic is looking to standardize its part, bill of material (BOM) and change management processes, in addition to collaborative engineering, design, product development, procurement management and strategic sourcing. Siemens Dematic will also use the solution provider's Program Management Central and Engineering Central applications.

Finally, Amersham Biosciences, a provider of integrated systems and solutions for disease research and drug development, has tapped MatrixOne to unify and support its product development processes in research and development (R&D) and manufacturing engineering, as well as to streamline product information management. In addition to deploying eMatrix, Amersham will implement Engineering Central to replace its current product data management (PDM) system in order to facilitate the development of instruments, software and chemical reagents in biotechnological research and manufacture.

"Realizing the 'develop anywhere and produce anywhere' paradigm is very important to achieve the flexibility needed to be a leader in this dynamic business space, said Bengt-Ake Nilsson, vice president of information management at Amersham Biosciences. "This project will assist us to face future challenges and keep us ahead of our competition in the ever-faster moving biotech market."

Amersham Biosciences was formed in August 1997 when Amersham plc and Pharmacia Corporation merged their respective life science businesses. The company is headquartered in Uppsala, Sweden.

MatrixOne's partner in the Nordic region of Europe, Technia AB, was chosen to support the initiative at Amersham Biosciences.